IBDEI10D ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36596,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,36596,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,36596,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,36597,0)
 ;;=F02.80^^135^1800^45
 ;;^UTILITY(U,$J,358.3,36597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36597,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob PARKINSON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,36597,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,36597,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,36598,0)
 ;;=G31.84^^135^1800^62
 ;;^UTILITY(U,$J,358.3,36598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36598,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PARKINSON'S DISEASE
 ;;^UTILITY(U,$J,358.3,36598,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,36598,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,36599,0)
 ;;=A81.9^^135^1800^71
 ;;^UTILITY(U,$J,358.3,36599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36599,1,3,0)
 ;;=3^Prion Disease
 ;;^UTILITY(U,$J,358.3,36599,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,36599,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,36600,0)
 ;;=F02.81^^135^1800^32
 ;;^UTILITY(U,$J,358.3,36600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36600,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,36600,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,36600,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,36601,0)
 ;;=F02.80^^135^1800^33
 ;;^UTILITY(U,$J,358.3,36601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36601,1,3,0)
 ;;=3^Major Neurocog D/O d/t PRION DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,36601,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,36601,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,36602,0)
 ;;=G31.84^^135^1800^63
 ;;^UTILITY(U,$J,358.3,36602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36602,1,3,0)
 ;;=3^Mild Neurocog D/O d/t PRION DISEASE
 ;;^UTILITY(U,$J,358.3,36602,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,36602,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,36603,0)
 ;;=S06.2X9S^^135^1800^74
 ;;^UTILITY(U,$J,358.3,36603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36603,1,3,0)
 ;;=3^TRAUMATIC BRAIN INJURY,Diffuse w/ Unspec Duration of LOC,Sequela
 ;;^UTILITY(U,$J,358.3,36603,1,4,0)
 ;;=4^S06.2X9S
 ;;^UTILITY(U,$J,358.3,36603,2)
 ;;=^5020755
 ;;^UTILITY(U,$J,358.3,36604,0)
 ;;=F02.81^^135^1800^50
 ;;^UTILITY(U,$J,358.3,36604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36604,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,36604,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,36604,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,36605,0)
 ;;=F02.80^^135^1800^51
 ;;^UTILITY(U,$J,358.3,36605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36605,1,3,0)
 ;;=3^Major Neurocog D/O d/t TBI w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,36605,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,36605,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,36606,0)
 ;;=G31.84^^135^1800^64
 ;;^UTILITY(U,$J,358.3,36606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36606,1,3,0)
 ;;=3^Mild Neurocog D/O d/t TBI
 ;;^UTILITY(U,$J,358.3,36606,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,36606,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,36607,0)
 ;;=F01.51^^135^1800^48
 ;;^UTILITY(U,$J,358.3,36607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36607,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,36607,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,36607,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,36608,0)
 ;;=F01.50^^135^1800^49
 ;;^UTILITY(U,$J,358.3,36608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36608,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,36608,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,36608,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,36609,0)
 ;;=G31.84^^135^1800^65
 ;;^UTILITY(U,$J,358.3,36609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36609,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,36609,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,36609,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,36610,0)
 ;;=R41.9^^135^1800^68
 ;;^UTILITY(U,$J,358.3,36610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36610,1,3,0)
 ;;=3^Neurocognitive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,36610,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,36610,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,36611,0)
 ;;=F06.31^^135^1801^1
 ;;^UTILITY(U,$J,358.3,36611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36611,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,36611,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,36611,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,36612,0)
 ;;=F06.32^^135^1801^2
 ;;^UTILITY(U,$J,358.3,36612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36612,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
 ;;^UTILITY(U,$J,358.3,36612,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,36612,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,36613,0)
 ;;=F32.9^^135^1801^20
 ;;^UTILITY(U,$J,358.3,36613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36613,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,36613,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,36613,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,36614,0)
 ;;=F32.0^^135^1801^17
 ;;^UTILITY(U,$J,358.3,36614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36614,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,36614,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,36614,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,36615,0)
 ;;=F32.1^^135^1801^18
 ;;^UTILITY(U,$J,358.3,36615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36615,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,36615,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,36615,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,36616,0)
 ;;=F32.2^^135^1801^19
 ;;^UTILITY(U,$J,358.3,36616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36616,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,36616,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,36616,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,36617,0)
 ;;=F32.3^^135^1801^14
 ;;^UTILITY(U,$J,358.3,36617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36617,1,3,0)
 ;;=3^MDD,Single Episode w Psychotic Features
 ;;^UTILITY(U,$J,358.3,36617,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,36617,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,36618,0)
 ;;=F32.4^^135^1801^16
 ;;^UTILITY(U,$J,358.3,36618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36618,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,36618,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,36618,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,36619,0)
 ;;=F32.5^^135^1801^15
 ;;^UTILITY(U,$J,358.3,36619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36619,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,36619,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,36619,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,36620,0)
 ;;=F33.9^^135^1801^13
 ;;^UTILITY(U,$J,358.3,36620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36620,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,36620,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,36620,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,36621,0)
 ;;=F33.0^^135^1801^10
 ;;^UTILITY(U,$J,358.3,36621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36621,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,36621,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,36621,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,36622,0)
 ;;=F33.1^^135^1801^11
 ;;^UTILITY(U,$J,358.3,36622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36622,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,36622,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,36622,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,36623,0)
 ;;=F33.2^^135^1801^12
